健脾益肾法治疗肿瘤化疗后白细胞减少效果观察

To Observe the Effect of Tumor Leukopenia After Chemotherapy Treatment of Invigorating Spleen and Kidney

目的探讨健脾益肾法治疗肿瘤化疗后白细胞减少的效果。方法选取86例肿瘤化疗患者并随机分组,对照组给予常规治疗,观察组加用健脾益肾法治疗。结果观察组患者KPS评分平均为(86.48±3.56)分,其治疗总有效率为90.70%;对照组患者KPS评分平均为(70.41±3.11)分,其治疗总有效率为55.81%,两组差异显著。结论健脾益肾法治疗肿瘤化疗后白细胞减少的临床疗效显著。

Objective To investigate the effect of tumor treatment of leucopenia after chemotherapy of invigorating spleen and kidney. Methods 86 cases of cancer chemotherapy patients were randomly divided into two groups, the control group was given conventional treatment, the observation group treated with Yishen Jianpi treatment. Results The KPS score of observation group was（86.48±3.56）%, the total effective rate was 90.70%, the control group of patients with the average KPS score was（70.41±3.11）%, the total effective rate of treatment was 55.81%, Significant difference among the two groups. Conclusion The clinical curative effect of tumor leukopenia after chemotherapy treatment of invigorating spleen and kidney significantly.